1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Sato, A.
Kawaguchi, K.
Kimura, K.
Tanimura, R.
Sone, S.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
To be Published
0353
A peptide mimetic of IFN, the first proof of a small peptidic agonist for heterodimeric cytokine receptor
10.2210/pdb1id7/pdb
pdb_00001id7
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
1784.942
SYR6
1
syn
polymer
no
no
SVQARWEAAFDLDLY
SVQARWEAAFDLDLY
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2002-04-10
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
1ID6 contains the origninal 11 structures which were used for calculation of this average structure.
RCSB
Y
PDBJ
2001-04-04
REL
REL
chemically synthesized
sample
This structure was determined using standard 2D homonuclear techniques.
Average structure of the 11 structures with the least restraint violations
750
1
DQF-COSY
TOCSY
2D NOESY
ambient
293
K
The average structure of the 11 structures that are based on 66 NOE-derived
distance constraints.
4D simulated annealing
1
minimized average structure
2.0mM SYR6; deuterated dimethyl sulfoxide 100%
deuterated dimethyl sulfoxide 100%
Morikawa, S. et. al.
structure solution
EMBOSS
5.0
Morikawa, S. et. al.
refinement
EMBOSS
5.0
600
Varian
INOVA
n
1
1
A
VAL
2
n
2
VAL
2
A
GLN
3
n
3
GLN
3
A
ALA
4
n
4
ALA
4
A
ARG
5
n
5
ARG
5
A
TRP
6
n
6
TRP
6
A
GLU
7
n
7
GLU
7
A
ALA
8
n
8
ALA
8
A
ALA
9
n
9
ALA
9
A
PHE
10
n
10
PHE
10
A
ASP
11
n
11
ASP
11
A
LEU
12
n
12
LEU
12
A
ASP
13
n
13
ASP
13
A
n
14
14
A
n
15
15
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
SER
1
A
SER
1
1
Y
1
A
LEU
14
A
LEU
14
1
Y
1
A
TYR
15
A
TYR
15
1
Y
1
A
ALA
4
-13.94
1
A
GLN
3
-136.05
-38.54
1
A
ALA
4
58.58
-177.09
1
A
ARG
5
34.15
37.81
1
A
TRP
6
-145.62
-150.46
1
A
GLU
7
-36.87
-35.46
1
A
ALA
8
-156.57
-82.21
1
A
ALA
9
164.58
145.15
1
A
PHE
10
-124.56
-88.31
minimized average
SOLUTION STRUCTURE OF SYR6
1
N
N
ANTIVIRAL PROTEIN
SYR6, ANTIVIRAL PROTEIN
BAB62415
GB
1
15076606
1
15
1ID7
1
15
15076606
A
1
1
15